Brett Fishbin

Stock Analyst at Keybanc

(3.23)
# 1,002
Out of 4,784 analysts
29
Total ratings
48%
Success rate
3.66%
Average return

Stocks Rated by Brett Fishbin

ResMed
Jan 31, 2025
Maintains: Overweight
Price Target: $266$280
Current: $220.11
Upside: +27.21%
Simulations Plus
Jan 24, 2025
Maintains: Overweight
Price Target: $35$37
Current: $24.03
Upside: +53.97%
Integer Holdings
Jan 24, 2025
Maintains: Overweight
Price Target: $144$154
Current: $115.40
Upside: +33.45%
Inspire Medical Systems
Jan 24, 2025
Reiterates: Overweight
Price Target: $236$234
Current: $153.21
Upside: +52.73%
Alcon
Jan 24, 2025
Maintains: Overweight
Price Target: $107$105
Current: $94.65
Upside: +10.94%
ICU Medical
Nov 13, 2024
Maintains: Overweight
Price Target: $198$209
Current: $138.52
Upside: +50.89%
STERIS
Sep 3, 2024
Maintains: Overweight
Price Target: $255$265
Current: $223.20
Upside: +18.73%
UFP Technologies
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $196.95
Upside: -
Sotera Health Company
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $11.64
Upside: -
LeMaitre Vascular
Feb 6, 2024
Initiates: Sector Weight
Price Target: n/a
Current: $82.09
Upside: -
Initiates: Sector Weight
Price Target: n/a
Current: $83.15
Upside: -